...
首页> 外文期刊>British Journal of Haematology >Interactions between killer immunoglobulin-like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm.
【24h】

Interactions between killer immunoglobulin-like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm.

机译:杀伤性免疫球蛋白样受体与其人类白细胞抗原I类配体之间的相互作用影响地中海贫血的无关造血干细胞移植的结果:一种新颖的预测算法。

获取原文
获取原文并翻译 | 示例
           

摘要

In a study conducted on 114 patients undergoing unrelated donor haematopoietic stem cell transplantation (HSCT) for thalassaemia, we observed that the lack of activating killer immunoglobulin-like receptors (KIRs) on donor natural killer (NK) cells significantly increased the risk of graft-versus-host disease (GvHD) [hazard risk (HR) 4.2, 95% confidence interval (CI) 1.7-10.1, P = 0.002] and transplantation-related mortality (HR 4.7, 95% CI 1.6-14.2, P = 0.01). The risk of GvHD furthermore increased when recipients heterozygous for HLA-C KIR ligand groups (C1/C2) were transplanted from donors completely lacking activating KIRs (HR 6.1, 95% CI 1.9-19.2, P = 0.002). We also found that the risk of rejection was highest when the recipient was homozygous for the C2 HLA-KIR ligand group and the donor carried two or more activating KIRs (HR 6.8, 95% CI 1.9-24.4, P = 0.005). By interpolating the number of donor activating KIRs with recipient HLA-C KIR ligands, we created an algorithm capable of stratifying patients according to the immunogenetic risk of complications following unrelated HSCT. In clinical practice, this predictive tool could serve as an important supplement to clinical judgement and decision-making.
机译:在一项针对114名接受无关的地中海贫血供体造血干细胞移植(HSCT)的患者进行的研究中,我们观察到供体自然杀伤(NK)细胞缺乏激活的杀伤性免疫球蛋白样受体(KIR),这大大增加了移植的风险。对宿主疾病(GvHD)[危险风险(HR)4.2,95%置信区间(CI)1.7-10.1,P = 0.002]和移植相关死亡率(HR 4.7,95%CI 1.6-14.2,P = 0.01) 。当从完全缺乏活化KIR的供体移植HLA-C KIR配体组(C1 / C2)杂合体的受体时,GvHD的风险进一步增加(HR 6.1,95%CI 1.9-19.2,P = 0.002)。我们还发现,当接受者为C2 HLA-KIR配体组纯合子且供体携带两个或多个活化KIR时,排斥的风险最高(HR 6.8,95%CI 1.9-24.4,P = 0.005)。通过用受体HLA-C KIR配体插入供体激活KIR的数量,我们创建了一种能够根据无关HSCT并发症的免疫遗传风险对患者进行分层的算法。在临床实践中,这种预测工具可以作为临床判断和决策的重要补充。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号